Daiichi Sankyo, Ranbaxy To Launch Benicar In Mexico This Year
This article was originally published in PharmAsia News
Executive Summary
Daiichi Sankyo's Ranbaxy Laboratories plans to launch the parent firm's Benicar (olmesartan), a drug for high blood-pressure, in Mexico this year